tirzepatide diabetes trial monotherapy in Chinese patients with early type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 (SURPASS-CN-MONO) endocrinology #clinicaltrials | NEJM Group
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14










/assets/production/practices/dffa88faf9887b01856b18477151f6b695f51a4e/images/2751963.jpg)















